Page 2 - Kersten Bartelt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglutide is the active ingredient found in Ozempic, which is used for type 2 diabetes, and Wegovy, which ...

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglutide is the active ingredient found in Ozempic, which is used for type 2 diabetes, and Wegovy, which ...

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglutide is the active ingredient found in Ozempic, which is used for type 2 diabetes, and Wegovy, which ...

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglutide is the active ingredient found in Ozempic, which is used for type 2 diabetes, and Wegovy, which ...

Making breast cancer screenings an annual event could save women’s lives, new research suggests. In a study led by Epic Research, a health analytics firm based in Verona, Wisconsin, women who were screened for breast cancer on a yearly basis were shown to have a 17% lower risk of death by any cause compared to